Cargando…
The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
Background: Preoperative serum tumor markers have been widely used to predict prognosis in stage II and III colorectal cancer (CRC). However, few previous studies addressed the effect of increased preoperative numbers of tumor markers. Methods: Patients with stage II and III CRC who underwent curati...
Autores principales: | You, Weiqiang, Sheng, Nengquan, Yan, Li, Chen, Hongqi, Gong, Jianfeng, He, Zhenghui, Zheng, Kaiwen, Chen, Zhaohuan, Wang, Yafang, Tan, Gewen, Xie, Lu, Wang, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636282/ https://www.ncbi.nlm.nih.gov/pubmed/31333793 http://dx.doi.org/10.7150/jca.31660 |
Ejemplares similares
-
TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
por: Sheng, Nengquan, et al.
Publicado: (2018) -
MiR‐145 inhibits human colorectal cancer cell migration and invasion via PAK4‐dependent pathway
por: Sheng, Nengquan, et al.
Publicado: (2017) -
Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
por: You, Weiqiang, et al.
Publicado: (2020) -
Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022) -
Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study
por: Ren, Jiazi, et al.
Publicado: (2021)